DK1129721T3 - Anvendelsen af isolerede domæner af type IV collagen for at modificere celle- og vævsvekselvirkninger - Google Patents

Anvendelsen af isolerede domæner af type IV collagen for at modificere celle- og vævsvekselvirkninger

Info

Publication number
DK1129721T3
DK1129721T3 DK01108470T DK01108470T DK1129721T3 DK 1129721 T3 DK1129721 T3 DK 1129721T3 DK 01108470 T DK01108470 T DK 01108470T DK 01108470 T DK01108470 T DK 01108470T DK 1129721 T3 DK1129721 T3 DK 1129721T3
Authority
DK
Denmark
Prior art keywords
cell
collagen
type
mesoglea
blockage
Prior art date
Application number
DK01108470T
Other languages
Danish (da)
English (en)
Inventor
Michael P Sarras Jr
Billy G Hudson
Original Assignee
Univ Kansas Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Kansas Medical Center filed Critical Univ Kansas Medical Center
Application granted granted Critical
Publication of DK1129721T3 publication Critical patent/DK1129721T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998—Proteins not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
DK01108470T 1994-06-30 1995-06-30 Anvendelsen af isolerede domæner af type IV collagen for at modificere celle- og vævsvekselvirkninger DK1129721T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/268,969 US5567609A (en) 1994-06-30 1994-06-30 Use of isolated domains of type IV collagen to modify cell and tissue interactions
EP95926149A EP0767676B1 (de) 1994-06-30 1995-06-30 Verwendung von isolierten domänen des typ-iv-kollagens zur modifikation von zell- und gewebeinteraktionen

Publications (1)

Publication Number Publication Date
DK1129721T3 true DK1129721T3 (da) 2004-06-28

Family

ID=23025295

Family Applications (2)

Application Number Title Priority Date Filing Date
DK95926149T DK0767676T3 (da) 1994-06-30 1995-06-30 Anvendelse af isolerede domæner af type IV-kollagen til at modificere celle- og vævsvekselvirkninger
DK01108470T DK1129721T3 (da) 1994-06-30 1995-06-30 Anvendelsen af isolerede domæner af type IV collagen for at modificere celle- og vævsvekselvirkninger

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK95926149T DK0767676T3 (da) 1994-06-30 1995-06-30 Anvendelse af isolerede domæner af type IV-kollagen til at modificere celle- og vævsvekselvirkninger

Country Status (9)

Country Link
US (7) US5567609A (de)
EP (2) EP0767676B1 (de)
AT (2) ATE262922T1 (de)
AU (1) AU3000895A (de)
DE (2) DE69524094T2 (de)
DK (2) DK0767676T3 (de)
ES (2) ES2217050T3 (de)
PT (2) PT767676E (de)
WO (1) WO1996000582A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5567609A (en) 1994-06-30 1996-10-22 University Of Kansas Medical Center Use of isolated domains of type IV collagen to modify cell and tissue interactions
US6358735B1 (en) 1995-06-30 2002-03-19 University Of Kansas Medical Center Method for inhibiting angiogenesis and tumors with the isolated NC1 α3 chain monomer of type IV collagen
US6440729B1 (en) * 1995-06-30 2002-08-27 University Of Kansas Medical Center Treating angiogenesis-mediated diseases with the α2 monomer of type IV collagen
EP0878480A1 (de) * 1997-05-14 1998-11-18 H.W. Prof. Dr. Müller Verfahren zur Förderung der Nerven-Regenerierung
JP2002509895A (ja) * 1998-03-27 2002-04-02 ユニヴァースティ オブ カンザス メディカル センター 細胞および組織相互作用を修飾するためのｉｖ型コラーゲンの単離ドメインの使用
US6759047B1 (en) 1998-06-17 2004-07-06 Beth Israel Deaconess Hospital Corp. Anti-angiogenic proteins and methods of use thereof
US6962974B1 (en) 1998-06-17 2005-11-08 Beth Israel Deaconess Medical Center Anti-angiogenic proteins and fragments and methods of use thereof
CA2331332A1 (en) * 1998-06-17 1999-12-23 Raghuram Kalluri Anti-angiogenic proteins and methods of use thereof
US7387779B2 (en) 1998-06-17 2008-06-17 Beth Israel Deaconess Medical Center Anti-angiogenic proteins and fragments and methods of use thereof
US20010018579A1 (en) 1998-12-18 2001-08-30 Walter Klemp Disposable absorbent garment having stretchable side waist regions
WO2000059532A1 (en) * 1999-04-01 2000-10-12 Biostratum, Inc. The use of domains of type iv collagen t inhibit angiogenesis an tumour growth
US6893812B2 (en) * 2000-05-30 2005-05-17 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Three-dimensional ex vivo angiogenesis system
CN100447155C (zh) * 2001-05-23 2008-12-31 中国科学院上海上海生命科学研究院 具有抑制内皮细胞生长活性的重组人内皮生长抑制蛋白
WO2003012122A2 (en) 2001-07-27 2003-02-13 University Of Kansas Medical Center Crystallized structure of type iv collagen nc1 domain hexamer
WO2004067762A2 (en) * 2003-01-27 2004-08-12 University Of Kansas Medical Center Crystallized structure of type iv collagen nc1 domain hexamer
US20050100510A1 (en) * 2003-05-09 2005-05-12 Frank Falco Methods for using gadolinium as a contrast media
US7432413B2 (en) 2005-12-16 2008-10-07 The Procter And Gamble Company Disposable absorbent article having side panels with structurally, functionally and visually different regions
US8057450B2 (en) 2006-03-31 2011-11-15 The Procter & Gamble Company Absorbent article with sensation member
US8491558B2 (en) 2006-03-31 2013-07-23 The Procter & Gamble Company Absorbent article with impregnated sensation material for toilet training
US8664467B2 (en) 2006-03-31 2014-03-04 The Procter & Gamble Company Absorbent articles with feedback signal upon urination
CN102871802B (zh) 2006-12-04 2016-06-01 宝洁公司 包括图形的吸收制品
WO2009153783A1 (en) * 2008-06-16 2009-12-23 Mor Research Applications Ltd. Monitoring skin metabolism products for evaluating burn injury
WO2013170433A1 (en) 2012-05-15 2013-11-21 The Procter & Gamble Company Absorbent article having characteristic waist end

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5021404A (en) 1988-04-20 1991-06-04 The Children's Medical Center Corporation Angiostatic collagen modulators
US5567609A (en) * 1994-06-30 1996-10-22 University Of Kansas Medical Center Use of isolated domains of type IV collagen to modify cell and tissue interactions
US6440729B1 (en) * 1995-06-30 2002-08-27 University Of Kansas Medical Center Treating angiogenesis-mediated diseases with the α2 monomer of type IV collagen

Also Published As

Publication number Publication date
US5856184A (en) 1999-01-05
WO1996000582A1 (en) 1996-01-11
US6448222B1 (en) 2002-09-10
US20030013194A1 (en) 2003-01-16
DK0767676T3 (da) 2002-05-21
ES2164160T3 (es) 2002-02-16
PT767676E (pt) 2002-03-28
EP1129721A2 (de) 2001-09-05
DE69532835D1 (de) 2004-05-06
DE69524094T2 (de) 2002-04-18
PT1129721E (pt) 2004-07-30
US5567609A (en) 1996-10-22
US6419924B1 (en) 2002-07-16
US5691182A (en) 1997-11-25
EP0767676B1 (de) 2001-11-21
US6384012B1 (en) 2002-05-07
EP1129721A3 (de) 2001-11-14
US6680293B2 (en) 2004-01-20
ATE262922T1 (de) 2004-04-15
DE69532835T2 (de) 2005-02-10
EP1129721B1 (de) 2004-03-31
DE69524094D1 (de) 2002-01-03
EP0767676A1 (de) 1997-04-16
ATE209043T1 (de) 2001-12-15
ES2217050T3 (es) 2004-11-01
AU3000895A (en) 1996-01-25

Similar Documents

Publication Publication Date Title
DK1129721T3 (da) Anvendelsen af isolerede domæner af type IV collagen for at modificere celle- og vævsvekselvirkninger
BR9913586A (pt) Processos para controlar bioincrustação em um meio aquoso e para marcar biofilmes e agregados celulares em um meio aquoso
NO20003414D0 (no) Anvendelse av PPAR-<ypsilon> aktivatorer i dermatologi
DE69221443D1 (de) Flüssigkristallichtventil und Informationsprozessor unter Verwendung desselben
ES2169495T3 (es) Dispositivo de distribucion de productos fluidos.
DE69828872D1 (de) Tonerzusammensetzung zur Verwendung im Textildruck
NO911233D0 (no) Nye retinoider.
DE69914053D1 (de) Einrichtung zur Steuerung eines Elektromagneten, mit Erfassung von unbeabsichtigtem Bewegen des beweglichen Kerns eines Elektromagneten
SE9904586L (sv) Sätt vid bestrykning av en löpande bana samt anordning
DE69425870D1 (de) Entwicklungseinheit mit Vorrichtung zur Regelung der Entwicklermenge
ATE233801T1 (de) Flüssigkristallkompositmaterial und vorrichtung, die dieses enthält
DE69223700D1 (de) Zählerschaltung unter Verwendung eines Zählers vom Johnson-Typ und Anwendung derselben
CN208072262U (zh) 一种新型模块化可照明指路牌
BR9905637A (pt) Processo para distribuir energia numa rede de abastecimento de corrente
DE59901145D1 (de) Sicherungseinsatz
FI954103A (fi) Suljettu syöttöjärjestelmä nestemäistä polttoainetta varten
ES2119686B1 (es) Colorantes dispersos.
EP0697291A4 (de) 4-hydroxy-4'-isopropoxydiphenylsulfon-entwicklerzusammensetzungen, nasspulverisierungsverfahren und dispersion
DE69934968D1 (de) Breitbandiger übergang von mikrostreifenleitung auf parallelplatten-hohlleiter
DE69216253D1 (de) 2-(2-benzo b thienyl)-3-methoxyacrylat- und -2-iminoacetat-derivate zur verwendung als pestizide
Liu Problems in management of the Yellow River.
Liu et al. An experimental study on the drifting speeds of card and raw oil film.
DE69901206D1 (de) Farbphotographisches Negativmaterial mit modifizierter Verteilung des Fängers für Entwickleroxidationsprodukt
Scolieri Bethlehem to Idle Coke Oven
KR930011940A (ko) 조리기